Singapore markets closed

Iterum Therapeutics plc (ITRM)

NasdaqCM - NasdaqCM Delayed price. Currency in USD
Add to watchlist
1.5500-0.0200 (-1.27%)
At close: 04:00PM EDT
1.5700 +0.02 (+1.29%)
After hours: 04:08PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 25.66M
Enterprise value 20.69M
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)N/A
Price/book (mrq)6.03
Enterprise value/revenue 105.22
Enterprise value/EBITDA -0.60

Trading information

Stock price history

Beta (5Y monthly) 2.36
52-week change 342.34%
S&P500 52-week change 322.38%
52-week high 32.5000
52-week low 30.6220
50-day moving average 31.5255
200-day moving average 31.3133

Share statistics

Avg vol (3-month) 3203.88k
Avg vol (10-day) 3163.51k
Shares outstanding 516.55M
Implied shares outstanding 616.55M
Float 815.34M
% held by insiders 11.50%
% held by institutions 17.66%
Shares short (15 Apr 2024) 41.2M
Short ratio (15 Apr 2024) 47.09
Short % of float (15 Apr 2024) 47.42%
Short % of shares outstanding (15 Apr 2024) 47.29%
Shares short (prior month 15 Mar 2024) 41.21M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 21:15
Last split date 318 Aug 2022

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Dec 2023

Profitability

Profit margin 0.00%
Operating margin (ttm)0.00%

Management effectiveness

Return on assets (ttm)-63.74%
Return on equity (ttm)-355.35%

Income statement

Revenue (ttm)N/A
Revenue per share (ttm)N/A
Quarterly revenue growth (yoy)N/A
Gross profit (ttm)N/A
EBITDA -45.72M
Net income avi to common (ttm)-38.37M
Diluted EPS (ttm)-2.9600
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)23.93M
Total cash per share (mrq)1.46
Total debt (mrq)19.51M
Total debt/equity (mrq)N/A
Current ratio (mrq)1.89
Book value per share (mrq)-0.47

Cash flow statement

Operating cash flow (ttm)-39.33M
Levered free cash flow (ttm)-22.38M